Yoshihiro Yoneda Appointed President of the International Human Frontier Science Program Organization
STRASBOURG, France, June 26, 2024 /PRNewswire/ -- The International Human Frontier Science Program Organization (HFSPO) is pleased to announce that acclaimed Japanese cell biologist and international research leader Yoshihiro Yoneda will assume the role of President for the global life science organization. Yoshihiro Yoneda Appointed President of HFSPO "We...
AXA Introduces New TotalAssure Critical Illness Series
Prioritises pre-emptive care for three early risk conditions with continuous support throughout the health journey Study reveals that nearly 90% of Hong Kong residents are not fully aware of their health conditions, putting them at higher risk of critical illness as early disease signs go undetected HONG KONG, June 25, 2024 /PRNewswire/ -- AXA Hong Kong and Macau ("AXA") unveiled...
ONO PHARMA USA Announces Support for Conquer Cancer®, the ASCO Foundation
Conquer Cancer Supports Cancer Research and Education CAMBRIDGE, Mass., June 25, 2024 /PRNewswire/ -- ONO PHARMA USA today announced it will provide a sponsorship to Conquer Cancer®, the ASCO Foundation, with $1 million funding to advance cancer research and education. Conquer Cancer is a global community of advocates, patients, doctors, researchers,...
Endogenex™ Announces $88 Million Series C Financing to Complete Pivotal Trial of the ReCET™ System in Patients with Type 2 Diabetes
Oversubscribed financing led by strategic investor, with participation from new and existing investors MINNEAPOLIS, June 25, 2024 /PRNewswire/ -- Endogenex, a clinical-stage medical device company dedicated to improving outcomes in individuals with type 2 diabetes, announced it has closed an oversubscribed Series C financing totaling $88 million. The new capital will be...
Porton Advanced introduces the MaxCyte ExPERT GTx Flow Electroporation instrument, continuing to provide customers with end-to-end cell and gene therapy CRO & CDMO services
SUZHOU, China, June 25, 2024 /PRNewswire/ -- Porton Advanced recently introduced the MaxCyte cGMP-grade ExPERT GTx Flow Electroporation instrument to its cell therapy platform, marking the company as the first cell therapy CDMO in China to possess this clinical-grade flow electroporation system. This equipment, known for its exceptional high transfection efficiency and cell viability, is capable of handling flexible...
Metabolon Receives NIH Grant to Develop Advanced Monitoring and Predictive Tools for Type 1 Diabetes Progression
MORRISVILLE, N.C., June 25, 2024 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, is proud to announce the receipt of a prestigious grant from the National Institutes of Health (NIH) to develop an innovative...
CLL Community Urges Hospital Authority to List Next-Generation BTK Inhibitor on Drug Formulary to Bring Hope and Improve Quality of Life for CLL Patients
HONG KONG, June 25, 2024 /PRNewswire/ -- Chronic Lymphocytic Leukaemia ('CLL') is a lymphoproliferative disease characterised by the abnormal proliferation of lymphocytes. The progression of CLL is relatively slow and it is a mild haematological malignancy. Cypress Charitable Trust is a Hong Kong government approved charity advocating for the betterment of the CLL community. As an independent organisation supporting CLL patients, Cypress...
NX Group Signs Strategic Partnership Agreement with Controlant of Iceland
- Set to Provide Real-time Monitoring Service for Tracking Cargo Location and Strict Temperature Control - TOKYO, June 25, 2024 /PRNewswire/ -- NIPPON EXPRESS HOLDINGS, INC. has signed a strategic partnership agreement with Iceland-based Controlant, Inc., a leading provider of real-time monitoring devices for pharmaceuticals. Controlant's logo: https://kyodonewsprwire.jp/img/202406202471-O1-sXfsB050 NX's logo: https://kyodonewsprwire.jp/img/202406202471-O3-jlufE0EU Image: https://cdn.kyodonewsprwire.jp/prwfile/release/M103866/202406202471/_prw_PI2fl_jHGSHe9r.png Headquartered in Iceland, Controlant, a...
Singclean: Unveiled Singfiller® and Singderm® in IMCAS ASIA 2024, Poised for Thailand’s Big Launch
BANGKOK, June 25, 2024 /PRNewswire/ -- Singclean, a global player and a leading Chinese manufacturer of high-quality medical aesthetic products, was excited to announce in IMCAS Asia that Singfiller® and Singderm® HA fillers will launch in Thailand this November. Although still not officially certified in Thailand, Singfiller® and Singderm®'s global excellent performance and good reputation have sparked interest among...
Innovent Presents the Results of the First Phase 3 Study of Mazdutide for Weight Management at the ADA’s 84th Scientific Sessions
SAN FRANCISCO and SUZHOU, China, June 25, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major diseases, presents the key results of the first Phase 3 clinical trial of mazdutide in Chinese adults with overweight...
